Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
8
Number of overlapping holdings
26.7%
% of MEDX's 30 holdings also in PJP
36.4%
% of PJP's 22 holdings also in MEDX
Overlap by Weight
Sector Drift (MEDX minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
AMGEN INC | 6.1% | 6.3% | 6.1% |
|
ELI LILLY & CO | 15.1% | 5.8% | 5.8% |
|
ABBVIE INC | 7.3% | 5.2% | 5.2% |
|
MERCK & CO. INC. | 5.2% | 5.8% | 5.2% |
|
JOHNSON & JOHNSON | 4.5% | 5.4% | 4.5% |
Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to PJP
|
ELI LILLY & CO | 9.3% |
 |
NOVARTIS AG-ADR | 5.8% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.7% |
|
BRISTOL-MYERS SQUIBB CO | 4.7% |
 |
ALKERMES PLC | 3.3% |
|
CRISPR THERAPEUTICS AG | 3.2% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 3.0% |
|
IONIS PHARMACEUTICALS, INC. | 2.9% |
|
ALNYLAM PHARMACEUTICALS INC | 2.6% |
|
INTELLIA THERAPEUTICS, INC. | 2.1% |
MEDX Underweight Relative to PJP
|
GERON CORP | -6.9% |
|
ABBOTT LABORATORIES | -5.1% |
|
UNITED THERAPEUTICS CORP | -4.4% |
|
LIGAND PHARMACEUTICALS-CL B | -4.3% |
|
CORCEPT THERAPEUTICS INC | -4.3% |
|
BIOSANTE PHARMACEUTICALS INC | -4.1% |
|
SUPERNUS PHARMACEUTICALS INC | -3.7% |
|
PRESTIGE BRANDS HOLDINGS INC | -3.6% |
|
INNOVIVA, INC. | -3.5% |
|
PACIRA PHARMACEUTICALS INC | -3.5% |